Showing results (721-730 of 1,072) with videos related to
Sort By:
Pageof 108
The American Journal of Cardiology|August 1, 1984
Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failureB F Uretsky, T Generalovich, P S Reddy, et al.Bone|June 23, 2006
Increasing sex difference in bone strength in old age: The Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK)Gunnar Sigurdsson, Thor Aspelund, Milan Chang, et al.Journal of Neurosurgery|April 15, 2017
The surgical treatment of tumors of the fourth ventricle: a single-institution experienceSherise D Ferguson, Nicholas B Levine, Dima Suki, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapyW Scheithauer, G V Kornek, B Schuell, et al.Clinical Nephrology|May 31, 2002
Analysis of the genes SLC7A9 and SLC3A1 in unclassified cystinurics: mutation detection rates and association between variants in SLC7A9 and the diseaseC Schmidt, A Albers, J Tomiuk, et al.Journal of Neurosurgery|September 13, 2011
Neurocognitive function before and after surgery for insular gliomasAdam S Wu, Mariana E Witgert, Frederick F Lang, et al.European Journal of Clinical Nutrition|May 23, 2013
Relation between urinary hydration biomarkers and total fluid intake in healthy adultsE Perrier, P Rondeau, M Poupin, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 28, 2024
Collision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytomaVinodh A Kumar, Alejandro Perez, Angela L Young, et al.International Journal of Cancer|July 20, 2000
Stereotactic radiosurgery for brain metastases: results and prognostic factorsM H Maor, P Dubey, S L Tucker, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapyH Ulrich-Pur, G V Kornek, W Fiebiger, et al.Pageof 108